Hypoxia-inducible factors (HIFs) mediate the transcriptional adaptation of hypoxic cells. The extensive transcriptional programm regulated by HIFs involves the induction of genes controlling angiogenesis, cellular metabolism, cell growth, metastasis, apoptosis, extracellular matrix remodeling and others. HIF is a heterodimer of HIF-a and HIF-b subunits. In addition to HIF-1a, HIF-2a has evolved as an isoform that contributes differently to the hypoxic adaptation by performing non-redundant functions. Poly (ADPribose) polymerase-1 (PARP-1) is a nuclear protein involved in the control of DNA repair and gene transcription by modulating chromatin structure and acting as part of gene-specific enhancer/promoter-binding complexes. Previous results have shown that PARP-1 regulates HIF-1 activity. In this study, we focused on the cross-talk between HIF-2a and PARP-1. By using different approaches to suppress PARP-1, we show that HIF-2a mRNA expression, protein levels and HIF-2-dependent gene expression, such as ANGPTL4 and erythropoietin (EPO), are regulated by PARP-1. This regulation occurs at both the transcriptional and posttrancriptional level. We also show a complex formation between HIF-2a with PARP-1. This complex is sensitive to PARP inhibition and seems to protect against the von Hippel-Lindau-dependent HIF-2a degradation. Finally, we show that parp-1 À / À mice display a significant reduction in the circulating hypoxia-induced EPO levels, number of red cells and hemoglobin concentration. Altogether, these results reveal a complex functional interaction between PARP-1 and the HIF system and suggest that PARP-1 is involved in the fine tuning of the HIF-mediated hypoxic response in vivo.
INTRODUCTION
When oxygen (O 2 ) availability decreases (hypoxia), the transcription of specific genes engaged in adaptive mechanisms such as glucose transport, glycolysis, erythropoiesis or angiogenesis is quickly increased. [1] [2] [3] [4] The hypoxia-inducible factor (HIF) mediates the upregulation of many of these hypoxia-regulated genes. HIF is a heterodimer of a-and b-subunits 5 that binds to target genes through cis-acting hypoxia-response elements. 6 To date, three HIFa isoforms have been described, with HIF-1a and HIF-2a being the best characterized.
The HIF-a subunits are regulated by O 2 availability, whereas HIF-b remains largely unaffected by changes in O 2 levels. Under normoxic conditions, HIF-a subunits are constitutively translated and degraded by the proteasome. HIF-a is indeed rapidly recognized by the product of the von Hippel-Lindau (pVHL) tumor-suppressor gene, 7 that targets the protein for degradation. pVHL recognition of HIF-a is dependent on hydroxylation of specific proline residues 8, 9 by a family of prolyl hydroxylase domain-containing proteins (PHDs). 10, 11 Three different PHDs (PHD1, PHD2 and PHD3) acting as critical O 2 sensors have been characterized in mammals. Under hypoxic conditions, hydroxylation is inhibited resulting in increased HIF-a stability; HIF-a translocates into the nucleus and heterodimerizes with the HIF-b subunit and thus form the active HIF complex. Moreover, HIF-a is hydroxylated on an asparagine residue by factor-inhibiting HIF, which is subjected to similar O 2 -dependent regulatory mechanisms as the PHDs and suppresses HIF transcriptional activity under normoxic conditions by blocking its association with the coactivator p300/CBP. 12 The HIF-2a subunit, also known as endothelial PAS domain protein-1, shares 48% amino-acid sequence identity with HIF-1a. 13 Despite these similarities, targeted disruption of the HIF-1a or HIF-2a gene in mice results in strikingly different phenotypes, demonstrating non-redundancy of their functions during embryonic development. [14] [15] [16] [17] Furthermore, HIF-2a knock-in did not rescue a HIF-1a null phenotype. 18 Thus, it is accepted that HIF-1 and HIF-2 contribute differently to the hypoxic adaptation by regulating the expression of overlapping but non-identical target genes. 19 Transcriptional activation by HIF-2 regulates some target genes in common with HIF-1, as well as other genes that are uniquely regulated by HIF-2. For example, HIF-2 regulates expression of erythropoietin (EPO), 20 induction of PHD2 is exclusive of HIF-1, whereas HIF-1 and HIF-2 induce PHD3. 21 HIF-1 and HIF-2 show even opposite effects on cell proliferation through c-MYC regulation. 22, 23 Some mechanisms have been proposed to account for HIF-1 and HIF-2 specificities. 24, 25 In the present work, we studied the impact of poly (ADP-ribose) polymerase-1 (PARP-1) on HIF-2-dependent response to hypoxia and the regulation of HIF-2 signaling by PARP-1. PARP-1 is an abundant nuclear enzyme that uses NAD þ as a substrate to catalyze the covalent attachment of ADP-ribose units on nuclear acceptor proteins or on PARP-1 itself. 1 Institute of Parasitology and Biomedicine Ló pez-Neyra, CSIC, Granada, Spain;
The resulting PAR alters the functional properties of the different target proteins, with consequences in a number of biological functions. 26 Initially, it was assumed that PARP-1 was primarily involved in DNA repair, but additional studies have provided evidence that PARP-1 acts also as a component of enhancer/ promoter regulatory complexes. 27, 28 We found that PARP-1 interacts with HIF-2a, and PARP inhibition affected complex formation and HIF-2a protein stability. Interestingly, PARP-1 was also found to be present at the HIF-2a promoter. PARP-1 depletion strongly decreased HIF-2a mRNA and, consequently, protein levels, as well as the transcription of HIF-2-dependent genes. Accordingly, hypoxia-induced EPO synthesis, mainly regulated by HIF-2, as well as the number of red cells and hemoglobin concentration, was also decreased at systemic level in PARP-1-knockout mice. Therefore, we conclude that PARP-1 ablation/inhibition exerts multiple regulatory actions on the HIF-2-mediated hypoxic response at transcriptional and posttranscriptional level.
RESULTS PARP-1 impacts on hypoxia-dependent HIF-2a accumulation PARP-1 has been shown to have an impact on HIF-1 activation in different settings, 29, 30 however, the interaction between PARP-1 and HIF-2a remains unknown. To evaluate the effect of PARP-1 on HIF-2a levels, we measured the accumulation of HIF-2a upon hypoxia in mouse embryonic fibroblasts (MEFs) derived from wildtype and knocknout PARP-1 mice (Figure 1a ). Hypoxic induction of HIF-2a was impaired in parp-1 À / À MEFs. Nuclear accumulation of HIF-2a was also prevented in PARP-1-knockout cells upon hypoxia (Supplementary Figure S1) . To ascertain that the above effect is specific of PARP-1 ablation, we knocked down PARP-1 by small interfering RNA (siRNA). Indeed, silencing of PARP-1 affected hypoxic induction of HIF-2a protein levels (Figure 1b) . Validation of our siRNAs targeting PARP-1, by transient transfection of the human embryonic kidney cells HEK 293T, is presented in Supplementary Figure S2 . Furthermore, treatment of the cells with PJ34, a PARP-1 inhibitor, decreased the expression levels of Flag-HIF-2a in normoxia as well as in hypoxia (Figure 1c) . We also confirmed the previous results with the endogenous protein (Figure 1d ). To test whether PARP-1 was affecting HIF-2a stability, the human renal carcinoma-derived cells RCC4 ( ± pVHL) were incubated in the absence or presence of the PARP-1 inhibitor, PJ34 (Figure 1e) . In RCC4 cells, HIF-2a protein levels did not change in response to PJ34 either in normoxia or in hypoxia. In contrast, PARP-1 inhibition decreased the barely detectable expression of HIF-2a in normoxia and completely abolished hypoxic induction of the protein upon hypoxia in pVHL-restored RCC4 cells. All these results strongly suggested that PARP-1 has an impacts on pVHLmediated HIF-2a stabilization and accumulation. Furthermore, PARP-1 activity is required in this process.
PARP-1 controls HIF-2a mRNA levels HIF-2a mRNA levels also decreased drastically in immortalized parp-1 À / À MEFs compared with parp-1 þ / þ cells both under normoxic and hypoxic conditions (Figure 2a) . Similarly, silencing of PARP-1 affected basal HIF-2a mRNA levels (Figure 2b ), suggesting that transcriptional regulation of HIF-2a was impaired in the absence of PARP-1 under both normoxic and hypoxic conditions. However, PARP-1 inhibition does not affect HIF-2a mRNA levels, contrary to what happens at the protein levels. Therefore, PARP-1 seems to impact on HIF-2a expression at the mRNA and protein levels through different mechanisms. 
HIF-2a form a complex with PARP-1 that increases during hypoxia
To investigate the molecular mechanisms of PARP-1-mediated regulation of HIF-2a protein accumulation, we evaluated whether both proteins physically interact, as previously shown for PARP-1 and HIF-1a. 30 We immunoprecipitated HIF-2a from RCC4 wholecell extracts and tested for the presence of PARP-1 by western blot analysis. HIF-2a formed a complex with PARP-1, which was increased upon hypoxia ( Figure 3a) . Moreover, the presence of the PARP-1 inhibitor, PJ34, resulted in a strong decrease of the complex upon hypoxia. Immunoprecipitation with anti-PARP-1 was also able to pull down HIF-2a (data not shown). Similar binding was also observed for overexpressed Flag-HIF-2a with endogenous PARP-1 protein, and this complex was dependent on PARP activity (Figure 3b ). g-irradiation of the cells to activate PARP did not further increase PARP-1 and HIF-2a complex formation ( Figure 3c ).
PARP-1 controls HIF-2a transcription
To explore whether PARP-1 was implicated in the regulation of HIF-2a transcription, we performed chromatin immunoprecipitation analysis. PARP-1 binds to the HIF-2a promotor as it did to a well-known binding site within the inducible nitric oxide synthase promoter and not to an intronic region of HIF-2a used as a positive and negative control, respectively (Figure 4a ). Furthermore, PARP-1 did not bind to the HIF-1a promoter, suggesting a specific mechanism in the activation of HIF-2 gene expression by PARP-1. PARP-1 binding to the HIF-2a promoter was confirmed by quantitative PCR (Figure 4b ). These results suggest that PARP-1 specifically binds to the HIF-2a promoter and may regulate HIF-2a expression at transcriptional level.
HIF-2 signaling and PARP-1 We next addressed whether PARP-1 or its inhibition affected HIF-2-dependent gene expression. Using a hypoxic array, we identified ANGPTL4 as the most differentially expressed gene between parp-1 þ / þ and parp-1 À / À cells upon hypoxia (data not shown). Interestingly, ANGPTL4 is induced by hypoxia and has been described as a HIF-dependent gene (Imamura et al., 2009).
We validated these data by analyzing the expression of different HIF-target genes in MEFs derived from wild-type and knocknout PARP-1 mice by quantitative PCR. Hypoxic induction of ANGPTL4 and PHD3 was strongly abolished in parp-1 À / À MEFs, whereas BNIP-3 or PHD2 expression was not affected (Figure 5a ; data not shown). To further confirm the specific role of PARP-1 in the control of HIF-2-dependent target genes, we silenced PARP-1, HIF2a or HIF-1a and analyzed the expression of ANGPTL4 and BNIP-3, which expression is HIF-1-and HIF-2-dependent or exclusively HIF-1-dependent, respectively (Figure 5b) . Silencing of PARP-1 reduced significantly the hypoxic induction of ANGPTL4 that was indeed completely blocked following HIF-2a silencing, whereas BNIP-3 expression was not affected by PARP-1 nor HIF2a silencing. Thus, knocking down of PARP-1 significantly reduced hypoxia-induced ANGPTL4 expression. Moroever, hypoxia was unable to induce ANGPTL4 following HIF-2a silencing, whereas ablation of HIF-1a still allows hypoxia-dependent ANGPTL4 induction. In contrast, in the case of BNIP-3 (which is a wellknown and specific HIF-1 target), HIF-1a silencing completely prevented hypoxia-induced BNIP-3 expression, whereas neither HIF-2a or PARP-1 silencing affected hypoxia-induced BNIP-3 expression. Furthermore, reintroduction of PARP-1 into the parp-1 À / À MEFs restored ANGPTL4 mRNA ( Figure 5c ) and protein levels (data not shown). Finally, supporting our previous data, PARP inhibition, using PJ34, also affected the hypoxia-induced expression of HIF-2-dependent genes such as ANGPTL4 and PHD3 (Figure 5d ).
PARP-1 contributes to EPO regulation in mice
To evaluate the physiological relevance of our finding, we decided to study the regulation of EPO expression, which is mainly driven by HIF-2 at the transcriptional level. First, we measured EPO mRNA upon hypoxia in parp-1 þ / þ and parp-1 À / À MEFs ( Figure 6a ). As expected, hypoxia-induced expression of EPO was significantly reduced in parp-1-deficient cells. Similar inhibition was measured when we inhibited PARP-1 activity by using PJ34 (Figure 6b) .
We next moved to study EPO in vivo regulation and measured circulating EPO levels in wild-type and PARP-1-knockout mice Regulation of HIF-2 by PARP-1 A Gonzalez-Flores et al exposed to hypoxia (Figure 6c ). EPO levels were reduced in parp-1 À / À mice compared with the wild-type animals, and thus, the in vivo data confirmed our in cellulo studies. Two hematological parameters, such as the number of red blood cells and the hemoglobin concentration, were accordingly reduced in parp-1 À / À mice after exposure to hypoxia (Figure 6d and e) . In addition, hypoxia-induced EPO mRNA declined in parp-1 À / À mice in both kidney and liver, which are the main sites of EPO synthesis, whereas in brain, EPO mRNA levels were not affected (Supplementary Figure S3) . These results agree with previous finding showing the predominant role of HIF-2 in maintaining EPO and iron homeostasis. 31 Therefore, functionally, parp-1 À / À mice reflect the defective HIF-2 activation, suggesting that PARP-1 might have an important function in the regulation of HIF-2-dependent physiological tuning.
DISCUSION
There are still many open questions about the specific role of PARP-1 in the hypoxic response as well as the partners of the hypoxic signaling implicated in the interaction with PARP-1. In Figure 7 , we summarized the current findings showing the Both HIF-2a and HIF-1a are expressed at high levels in a variety of human tumors and tumor cell lines, although the relative contribution of each protein to tumor initiation and progression is a rather contentious area. For reasons that remain unclear, in neoplastic epithelial cells of clear cell renal carcinomas, the normal predominance of HIF-1a expression in non-neoplastic renal tubules is strikingly altered in favor of HIF-2a expression. 32 Furthermore, genetic manipulation of clear cell renal carcinoma cells indicates that activation of HIF-2a but not HIF-1a promotes tumor growth. [33] [34] [35] [36] Hemangioblastomas, highly vascularized tumors of the central nervous system, are the most frequent manifestation of the autosomal-dominant-inherited VHL disease, and they show HIF-2a upregulation, 37 which determine neuroblastoma aggressiveness. 38 In view of the previous examples, HIF-2a could represent an important target in cancer therapy, and it would be very interesting to rely on a tool to specifically target HIF-2a and to counteract tumor development. Based on our results, PARP-1 appears as a good candidate at least in certain tumor models where inhibition of PARP activity might counteract HIF-1a and HIF-2a accumulation. Nonetheless, further studies are necessary to elucidate the molecular mechanism underlying the specific impact of PARP-1 on HIF-2a.
MATERIALS AND METHODS

Cell culture
Immortalized MEFs derived from both wild-type and knockout PARP-1 mice were grown as previously described. 39 RCC4 ± pVHL and COS cells were grown in Dulbecco's Modified Eagle medium supplemented with 10% fetal bovine serum plus penicillin (50 IU/ml) and streptomycin (50 mg/ml). Medium used for HEK 293T cells was Dulbecco's Modified Eagle medium low glucose supplemented with 10% fetal bovine serum, L-glutamine 4 mM, MEM non-essential amino acids 0.1 mM and antibiotics (Gibco, Paisley, UK). For normoxic conditions, cells were incubated in a regular incubator (21% O 2 , 5% CO 2 ). Hypoxic conditions (1% O 2 , 5% CO 2 ) were reached by incubation of cells in a sealed hypoxic workstation (Ruskinn, Bridgend, UK). 
Reagents and antibodies
The PARP inhibitor, PJ34 (N-(6-Oxo-5,6-dihydro-phenanthridin-2-yl)-(N,Ndimethylacetamide.HCl), was purchased from Enzo Life Sciences (San Diego, CA, USA) and it was used at a concentration of 10 mM. For western blot analysis, we used polyclonal anti-HIF-1a from Bethyl (Montgomery, TX, USA), polyclonal anti-HIF-2a from Novus Biologicals, monoclonal anti-PARP-1 (C2-10) from Alexis Biochemicals (San Diego, CA, USA) and monoclonal anti-b-actin from Sigma (St Louis, MO, USA). For coimmunoprecipitation assays, Protein A Sepharose-monoclonal anti-FLAG from Sigma and polyclonal anti-HIF-2a from Novus Biologicals were used. For chromatin immunoprecipitation analysis, polyclonal anti-PARP-1 from Alexis Biochemicals was used.
Co-immunoprecipitation
Cells were treated as indicated in the figure legends. To prepare cell extracts, cells were washed twice in phosphate-buffered saline, then collected with lysis buffer (1% NP-40, 100 mM NaCl, 20 mM Tris-Cl pH 7.6, 10 mM sodium pyrophosphate, 1 mM EGTA pH8.0, 10 mM NaF, 1 mM sodium orthovanadate, 500 mM phenylmethylsulfonyl fluoride and cocktail of proteases inhibitors (Complete Mini, Roche, Zurich, Switzerland)) and incubated on ice for 20 min. Cell lysates were first incubated with Protein A Sepharose. The precleared supernatants were incubated with anti-FLAG mAb, anti-PARP-1 pAb or anti-HIF-2a pAb antibodies plus Protein A Sepharose overnight at 4 1C. Immunoprecipitates were washed three times with phosphate-buffered saline. The immunoprecipitated complexes were boiled in SDS sample buffer, separated by SDS-PAGE on a 7.5% gel and then transferred to a polyvinylidene difluoride membrane. 
Quantitative PCR
After treatments, cells were washed with phosphate-buffered saline and collected for total RNA extraction with RNeasy Mini Kit from Qiagen (Hilden, Germany). For mRNA expression analysis, 500 ng of total RNA from each sample was retro-transcribed to cDNA (MultiScribe Reverse Transcriptase; Applied Biosystems, Carlsbad, CA, USA) and amplified with the quantitative PCR MasterMix Plus for SYBR Green I (Eurogentec, Liege, Belgium). PCR amplifications were carried out in an ABI PRISM 7000 Sequence Detection System (Applied Biosystems, Carlsbad, CA, USA) and data were analyzed with ABI PRISM 7000 SDS software. For each sample, duplicate determinations were made, and the mRNA copy number was normalized for the amount of Arbp in MEFs, and Rplp in RCC4 and HEK 293T cells. The primer sequences for quantitative PCR are available on request.
Western blotting
Cells were lysed and sonicated in Laemmli buffer after phosphate-buffered saline wash. The protein concentration was determined using the Lowry assay, and 60 mg for HIF-2a or 40 mg for PARP-1 of whole-cell extracts was resolved by SDS-PAGE (7.5%). Next, proteins were transferred onto a nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ, USA) for HIF-2a or polyvinylidene difluoride (Millipore, Billerica, MA, USA) for PARP-1. The same membranes were probed with anti-b-actin. Immunoreactive bands were visualized with the ECL system (Amersham Biosciences, Piscataway, NJ, USA).
In vivo experiments
Male C57/BL6 mice, wild-type or PARP-1 knockout, 39 were exposed to an O 2 concentration of 6% (or untreated) for different times as described in the figure legend.
Acute hypobaric hypoxia was induced by using a slight modification of a previously published procedure. 29 Briefly, animals were introduced into a Regulation of HIF-2 by PARP-1 A Gonzalez-Flores et al hypobaric chamber in which the air pressure was controlled by means of a continuous vacuum pump and an adjustable inflow valve. The chamber was also provided with a manometer to check the experimental values during the process. Hypoxia was induced by downregulation of the environmental pressure to 225 mm Hg, which results in a pO 2 partial pressure of 48 mm Hg, around 30% of the sea level value (equivalent to approximately 6% normobaric O 2 ). These conditions simulated an altitude of 31 000 ft (8100 m) and were maintained for 8 h. Ascent and descent rates were kept o1000 ft/min. After the hypoxia period, a return to normobaric normoxic conditions (pO 2 ¼ 150 mm Hg in our setting) was attained in E30 min. Animals were either killed immediately after the hypobaric chamber was opened or kept at atmospheric pressure for 5 days and then killed. Animals kept in the chamber under normobaric normoxic conditions served as controls.
Chromatin immunoprecipitation analysis
Chromatin from normoxic parp-1 þ / þ -and parp-1 À / À -immortalized MEFs was fixed with formaldehyde and immunoprecipitated initially with control IgGs and then overnight with anti-PARP-1 antibody following the protocol described by Pescador et al. 41 After DNA purification, the presence of the selected murine sequences was assessed by PCR amplification, and by quantitative PCR when it is indicated. The PCR products were resolved by gel electrophoresis and visualized by ethidium bromide staining.
Serum EPO and blood determinations in mice.
Serum EPO was analyzed by enzyme immunoassay in an UnicellTM DxI-800 (Beckman Coulter, Barcelona, Spain). Red blood cell count and hemoglobin concentration determination were performed in a Hematology System Advia 2120 Analyzer (Siemens Diagnostics, Deerfield, IL, USA).
Statistical analysis
Data are expressed as means±s.e.m. Statistical comparisons between the different indicated experimental groups were made by Student's t-test, accepting Po0.05 as the level of significance.
